Am J Transplant, Volume 21, Suppl 3 Archives - Page 85 of 139 - ATC Abstracts

2021 American Transplant Congress
Dosing Weight of Rabbit Antithymocyte Globulin and Outcomes Among Kidney Transplant Patients Treated for Rejection
C. Patton, K. Cunningham, C. D'Agostino, A. Novak, M. Kapugi, K. Lang, C. Kane
Pharmacy, Northwestern Memorial Hospital, Chicago, IL
*Purpose: Rabbit antithymocyte globulin (rATG) is FDA approved for kidney transplant induction therapy and treatment of T-cell mediated rejection (TCMR). While prior studies comparing dosing…
2021 American Transplant Congress
Sodium Zirconium Cyclosilicate Use in Kidney Transplant Recipients
K. J. Swanson, F. Aziz, S. Parajuli, M. Mohamed, D. A. Mandelbrot, A. Djamali, N. Garg
University of Wisconsin-Madison, Madison, WI
*Purpose: Hyperkalemia is a common problem experienced by kidney transplant recipients (KTR)s. New strategies to treat hyperkalemia are now available. KTRs often require medications that…
2021 American Transplant Congress
Preemptive Second Kidney Transplant Outcomes by Induction Type in the United States
S. Riad¹, G. Larrieux², S. Jackson³, R. Kandaswamy²
¹Medicine, University of Minnesota, Minneapolis, MN, ²Surgery, University of Minnesota, Minneapolis, MN, ³Complex Care Analytics, M-Health Fairview, Minneapolis, MN
*Purpose: Failed kidney allograft is the fourth leading indication for kidney transplantation. A significant portion of second kidney transplant recipients undergo preemptive transplantation while on…
2021 American Transplant Congress
Modeling of Alternative Weight-Based Dosing Strategies of LCP-Tacrolimus in De Novo Kidney Transplant Patients
J. D. Momper¹, S. J. Patel², M. A. Moten², D. R. Stevens², U. Meier-Kriesche²
¹Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, CA, ²Medical Affairs, Veloxis Pharmaceuticals, Cary, NC
*Purpose: LCP-tacrolimus (LCPT; Envarsus XR®) is a modified-release once-daily formulation approved for prophylaxis of organ rejection in de novo kidney transplant patients in combination with…
2021 American Transplant Congress
Very Long-Term Patient and Kidney Allograft Outcomes in Kidney Transplant Recipients More Than 20 Years After Transplantation:
T. Schachtner, A. Reimann, T. Müller
University Hospital Zurich, Zürich, Switzerland
*Purpose: Despite rapid medical advancements in the field of transplantation over the last decades, long-term kidney allograft survival only slowly improves. Especially little is known…
2021 American Transplant Congress
Multimodal Analgesia Reduces Length of Stay in Living Kidney Donors
K. Marti¹, D. O'Sullivan², X. Ye³, C. Rochon³, H. Kutzler³
¹Pharmacy, Hartford Hospital, Hartford, CT, ²Research Administration, Hartford Hospital, Hartford, CT, ³Transplant, Hartford Hospital, Hartford, CT
*Purpose: This study evaluated the outcomes between living kidney donors who received a multimodal analgesic regimen compared to a historical cohort that did not.*Methods: Hartford…
2021 American Transplant Congress
Evaluation of the Impact of Delayed Graft Function (dgf) on Kidney Allograft Outcomes
J. Leeds, B. Rawashdeh, M. Sestito, B. Sharma, J. Kamal, A. Kumar, A. AgarwalAA4VB, A. Doyle, S. Rao
University of Virginia, Charlottesville, VA
*Purpose: DGF is an important post-transplant complication that has early and long-term consequences on graft survival with increased relative risk of graft loss. DGF frequency…
2021 American Transplant Congress
Graft Loss in Adolescent and Young Adult Generation After Pediatric Kidney Transplantation: A Single Center Experience in Japan
Y. Aoki, Y. Hamasaki, M. Muramatsu, J. Hashimoto, M. Kubota, S. Shishido, K. Sakai
Nephrology, Toho University Faculty of Medicine, Tokyo, Japan
*Purpose: Kidney transplant recipients of all ages may have difficulty adhering to a strict treatment plan, adolescents and young adults are at particularly high risk…
2021 American Transplant Congress
Pediatric Kidney Transplant Recipients Frequently Experience Utis Regardless of Esrd Etiology
E. Spiwak, C. Nailescu, A. Schwaderer
Indiana University Department of Pediatrics Division of Nephrology, Indianapolis, IN
*Purpose: Urinary tract infections (UTIs) remain the most common type of infectious complication experienced by renal allograft recipients. UTIs in transplant patients most commonly occur…
2021 American Transplant Congress
The Clinical Significance of Preformed Anti-HLA-DQ Donor-specific Antibodies on Allograft Outcomes in Kidney Transplantation
S. Lee¹, C. Yang², B. Chung²
¹Seoul National University Hospital, Seoul, Korea, Republic of, ²Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of
*Purpose: De-novo anti-HLA-DQ donor-specific antibody (DSA) has been identified as a risk factor for late graft dysfunction and graft loss in kidney transplantation (KT). The…